首页 | 本学科首页   官方微博 | 高级检索  
     


Initial experience with Tc-99m-HM-PAO in the study of brain tumors
Authors:John W. Babich  Frank Keeling  Margaret A. Flower  Lazzaro Repetto  Anthony Whitton  Sue Fielding  Ann Fullbrook  Robert J. Ott  V. Ralph McCready
Affiliation:(1) Department of Medical Physics, The Royal Marsden Hospital, SM2 5PT Sutton, Surrey, UK;(2) Department of Nuclear Medicine, The Royal Marsden Hospital, SM2 5PT Sutton, Surrey, UK;(3) Department of Medicine, The Royal Marsden Hospital, SM2 5PT Sutton, Surrey, UK;(4) Department of Radiotherapy, The Royal Marsden Hospital, SM2 5PT Sutton, Surrey, UK;(5) Institute of Cancer Research, SM2 5PT Sutton, Surrey, UK
Abstract:
A preliminary study of the distribution of the 99mTc complex of hexamethylpropylene amine oxime (HM-PAO) in 12 patients with brain neoplasms before, during, and after radiotherapy has been performed. Untreated brain tumors were found to exhibit a range of 99mTc-HM-PAO uptake, varying from areas of markedly increased isotope activity to photopenic areas, when compared to normal brain tissue. A ratio of 99mTc-HM-PAO tumor uptake to contralateral normal tissue uptake was calculated prior to and during radiotherapy. This ratio tended to return towards unity in lesions responding to therapy. A predictable alteration in whole brain 99mTc-HM-PAO uptake during radiotherapy was not demonstrated. Unlike the radiolabeled amines, 99mTc-HM-PAO localizes in primary tumors, probably indicating that its uptake mechanism is independent of non specific amine receptors. 99mTc-HM-PAO may be useful in the study of brain tumor physiology and response to therapy.
Keywords:99mTc-HM-PAO  Brain tumors  Radiotherapy  Brain tumor perfusion
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号